Anacor Pharma posts psoriasis study results - Forbes

Anacor Pharma posts psoriasis study results Forbes Anacor Pharmaceuticals Inc. is reporting positive results from a mid-stage trial of a drug candidate designed to treat the cutis condition psoriasis . Anacor said Monday that the drug reduced psoriasis plaques by 26 percent after six weeks of the 12-week ... Anacor Pharmaceuticals Announces Positive Preliminary Results from Phase 2b ... MarketWatch (press release) Anacor Pharmaceuticals Inc Announces affirmative Preliminary Results From state of matter ... BioMedReports (subscription) Anacor Pharma Reports Preliminary Results From Phase 2b legal proceeding Of AN2728 RTT tidings all 40 news articles » Link To Article